Carmine N. Stengone, Director at KIORA PHARMACEUTICALS INC (KPRX), bought 1,250 shares at $3.68 ($5K) on 2024-09-11, disclosed to the SEC on 2024-09-12.
Open-market purchase of $5k KPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CTNM | SELL | 2026-07-08 | $40K | — | Filing → |
| CTNM | SELL | 2026-07-01 | $160K | — | Filing → |
| CTNM | SELL | 2026-02-26 | $227K | — | Filing → |